Perspectives and potential roles for the newly discovered NSP4 in the immune system

Expert Review of Clinical Immunology

Volumn 8, Issue 6, 2012, Pages 501-503

  Perera, Natascha C ^a,b   Jenne, Dieter E ^a,b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

arginine specificity; cathepsin C; cathepsin G; elastase; granule; proteinase 3; serpin; small molecule inhibitor; therapeutic target; tissue distribution

Indexed keywords

ROTAVIRUS NONSTRUCTURAL PROTEIN 4;

IMMUNE SYSTEM; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; ARGININE; HUMANS; IMMUNE SYSTEM; MICE; NEUTROPHILS; PANCREATIC ELASTASE; SERINE PROTEASES;

EID: 84866692169     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.39     Document Type: Review

References (18)

1. Borregaard N. Neutrophils, from marrow to microbes. Immunity 33(5), 657-670 (2010).
2. Roos D, Winterbourn CC. Immunology. Lethal weapons. Science 296(5568), 669-671 (2002).
3. Williams R. Killing controversy. J. Exp. Med. 203(11), 2404 (2006).
4. Belaaouaj A, McCarthy R, Baumann M et al. Mice lacking neutrophil elastase reveal impaired host defense against Gram negative bacterial sepsis. Nat. Med. 4(5), 615-618 (1998).
5. Weinrauch Y, Drujan D, Shapiro SD, Weiss J, Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 417(6884), 91-94 (2002).
6. McGrath ME, Gillmor SA, Fletterick RJ. Ecotin: lessons on survival in a protease-filled world. Protein Sci. 4(2), 141-148 (1995).
7. Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69(2), 197-206 (2001).
8. Kessenbrock K, Dau T, Jenne DE. Tailormade inflammation: how neutrophil serine proteases modulate the inflammatory response. J. Mol. Med. 89(1), 23-28 (2011).
9. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6(7), 541-550 (2006).
10. Weiss SJ. Tissue destruction by neutrophils. N. Engl. J. Med. 320(6), 365-376 (1989).
11. Groutas WC, Dou D, Alliston KR. Neutrophil elastase inhibitors. Expert Opin. Ther. Pat. 21(3), 339-354 (2011).
12. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol. Rev. 62(4), 726-759 (2010).
13. Lucas SD, Costa E, Guedes RC, Moreira R. Targeting COPD: Advances on low-molecular-weight inhibitors of human neutrophil elastase. Med. Res. Rev. doi:10.1002/med.20247 (2011) (Epub ahead of print).
14. Perera NC, Schilling O, Kittel H, Back W, Kremmer E, Jenne DE. NSP4, an elastaserelated protease in human neutrophils with arginine specificity. Proc. Natl Acad. Sci. USA 109(16), 6229-6234 (2012).
15. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26, 389-420 (2008).
16. Tripathi LP, Sowdhamini R. Genome-wide survey of prokaryotic serine proteases: analysis of distribution and domain architectures of five serine protease families in prokaryotes. BMC Genomics 9, 549 (2008).
17. Bode W, Meyer E Jr, Powers JC. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry 28(5), 1951-1963 (1989).
18. Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4(3), 337-360 (1995).